AI Medical Service Inc.
Development of global products for upper gastrointestinal endoscopic AI
As of March, 2025
| City | Year of Establishment | Founder |
|---|---|---|
| Toshima-ku, Tokyo | 2017 | Tomohiro Tada |
| Partner VC | Latest round of Fundraising | Valuation |
|---|---|---|
| - | Series C | Non-Disclosure |
- Contact Information: +81-3-6903-1028
- Inquiry form
- Website:AI Medical Service Inc.
Program name
Deep-Tech Startups Support Program
Business Plan
The objective is to develop endoscopic AI specifically for overseas demand.
Research Outline
This project aims to develop endoscopic AI specialized for overseas demand and achieve the PoC listed below.
- File an application for regulatory approval in Singapore.
- Demonstrate the technology of the product at the stage of unapproved medical device in Singapore.
- Complete a pilot study in the U.S. as a preliminary stage of prospective clinical trials.
| Phase | Business Area/Field | Research Period | Research Grant Amount |
|---|---|---|---|
| PCA | Healthcare | 2025-2026FY | JPY 639 million |
International collaborative technology demonstration
| Countries/Regions | Collaborative activity outline |
|---|---|
| U.S.A., Southeast Asia | In collaboration with local medical facilities in the U.S. and Southeast Asia, conduct clinical trials with the prototype AI and utilize the feedback in product development. In addition, the feasibility of the U.S. clinical trial design will be determined, leading to prospective clinical trials in the next phase. |
Last Updated : August 13, 2025